International Biotechnology (LON:IBT – Get Free Report) insider Alexa Henderson acquired 6,996 shares of the company’s stock in a transaction on Wednesday, February 19th. The stock was acquired at an average price of GBX 711 ($8.98) per share, for a total transaction of £49,741.56 ($62,844.67).
International Biotechnology Trading Up 0.6 %
IBT stock opened at GBX 720 ($9.10) on Friday. International Biotechnology has a 1-year low of GBX 596 ($7.53) and a 1-year high of GBX 736 ($9.30). The business’s 50 day simple moving average is GBX 702.28 and its 200 day simple moving average is GBX 691.58. The firm has a market capitalization of £258.63 million, a PE ratio of 6.87 and a beta of 0.21.
International Biotechnology Increases Dividend
The business also recently disclosed a dividend, which was paid on Friday, January 24th. Shareholders of record on Thursday, December 19th were issued a GBX 15.56 ($0.20) dividend. This is an increase from International Biotechnology’s previous dividend of $14.50. This represents a dividend yield of 2.21%. The ex-dividend date of this dividend was Thursday, December 19th. International Biotechnology’s payout ratio is currently 27.67%.
About International Biotechnology
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.
Recommended Stories
- Five stocks we like better than International Biotechnology
- How to Short a Stock in 5 Easy Steps
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What is a Secondary Public Offering? What Investors Need to Know
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.